I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Huo, Gengwei
59
results:
Search for persons
X
Format
Online (59)
Mediatypes
Articles (Online) (21)
OpenAccess-fulltext (38)
Sorted by: Relevance
Sorted by: Year
?
1
Cost-effectiveness of dostarlimab plus chemotherapy for pri..:
Huo, Gengwei
;
Song, Ying
;
Liu, Wei
..
Frontiers in Pharmacology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
2
Cost-effectiveness of first-line versus second-line use of ..:
Liu, Wenjie
;
Huo, Gengwei
;
Chen, Peng
Frontiers in Public Health. 12 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
3
Cost-effectiveness of pembrolizumab plus chemotherapy for a..:
Huo, Gengwei
;
Song, Ying
;
Chen, Peng
Journal of Gynecologic Oncology. 35 (2024) - p. , 2024
Link:
https://doi.org/10.3802/..
?
4
Cost-effectiveness of atezolizumab plus chemotherapy for ad..:
Huo, Gengwei
;
Song, Ying
;
Chen, Peng
Journal of Gynecologic Oncology. 35 (2024) - p. , 2024
Link:
https://doi.org/10.3802/..
?
5
Cost-effectiveness of tisotumab vedotin as a second- or thi..:
Huo, Gengwei
;
Liu, Wenjie
;
Chen, Peng
Journal of Gynecologic Oncology. 35 (2024) - p. , 2024
Link:
https://doi.org/10.3802/..
?
6
Osimertinib in the treatment of resected EGFR-mutated non-s..:
Huo, Gengwei
;
Song, Ying
;
Liu, Wenjie
..
Frontiers in Pharmacology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
7
Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oeso..:
Huo, Gengwei
;
Liu, Wenjie
;
Chen, Peng
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
8
Toripalimab plus chemotherapy vs. chemotherapy in patients ..:
Huo, Gengwei
;
Liu, Wenjie
;
Kang, Shuo
.
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
9
First-line tremelimumab plus durvalumab and chemotherapy ve..:
Liu, Wenjie
;
Huo, Gengwei
;
Chen, Peng
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/..
?
10
Clinical benefit of pembrolizumab in treatment of first lin..:
Liu, Wenjie
;
Huo, Gengwei
;
Chen, Peng
BMC Cancer. 23 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
11
TWF1 induces autophagy and accelerates malignant phenotype ..:
Wang, Yu
;
Zuo, Ran
;
Huo, Gengwei
...
The FASEB Journal. 37 (2023) 7 - p. , 2023
Link:
https://doi.org/10.1096/..
?
12
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits..:
Cui, Jinfang
;
He, Yuchao
;
Zhu, Fuyi
...
International Journal of Biological Sciences. 19 (2023) 13 - p. 4061-4081 , 2023
Link:
https://doi.org/10.7150/..
?
13
Efficacy of Atezolizumab for Advanced Non-Small Cell Lung C..:
Liu, Wenjie
;
Huo, Gengwei
;
Chen, Peng
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
14
Inhibitors of PD-1 in Non-Small Cell Lung Cancer: A Meta-An..:
Huo, Gengwei
;
Liu, Wenjie
;
Chen, Peng
Frontiers in Immunology. 13 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
15
Oncogenic role of TWF2 in human tumors: A pan-cancer analys..:
Liu, Wenjie
;
Huo, Gengwei
;
Chen, Peng
Open Medicine. 17 (2022) 1 - p. 1425-1437 , 2022
Link:
https://doi.org/10.1515/..
1-15